Bank of Montreal’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bank of Montreal’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,800	Closed	-$15K	–	4540
2022 Q1	$15K	Buy	+5,800	New	+$15.1K	﹤0.01%	3960
2021 Q2	–	Sell	-281	Closed	-$2K	–	5117
2021 Q1	$2K	Sell	281 -1,104	-80%	-$12.1K	﹤0.01%	4932
2020 Q4	$14K	Buy	1,385 +978	+240%	+$10.7K	﹤0.01%	4578
2020 Q3	$5K	Sell	407 -315	-44%	-$2.5K	﹤0.01%	4462
2020 Q2	$5K	Buy	+722	New	+$7.67K	﹤0.01%	4430
2020 Q1	–	Sell	-211	Closed	-$3K	–	4845
2019 Q4	$3K	Buy	+211	New	+$2.57K	﹤0.01%	4759

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Bank of Montreal's GRTX Position: Q2 2022 in Review

Bank of Montreal sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2022, closing a stake of 5,800 shares — an estimated $15K sold.

Bank of Montreal first reported a position in GRTX in Q4 2019 and held it in 6 quarters. The position peaked at $15K in Q1 2022. 39 funds tracked by Wall St. Rank hold GRTX as of Q2 2022.

Bank of Montreal reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Bank of Montreal sold 5,800 Galera Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $15K.
Bank of Montreal first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
Bank of Montreal's Galera Therapeutics, Inc. Common Stock position peaked at $15K in Q1 2022.
39 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.